JavaScript is disabled for your browser. Some features of this site may not work without it.
Neadjuvant Chemotherapy (NACT) with Epirubicin (EPI) Cisplatin (CDDP), Bleomycin (BLEO) (BEC) in Undifferentiated nasopharyngeal cancer (UCNT): Preliminary results an international (Int.) phase (PH) III trial